buddlejasaponin iv has been researched along with beta-escin in 7 studies
| Studies (buddlejasaponin iv) | Trials (buddlejasaponin iv) | Recent Studies (post-2010) (buddlejasaponin iv) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 14,137 | 211 | 6,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bernabé, M; Díaz-Lanza, AM; Sánchez-Contreras, S | 1 |
| Chen, J; Li, Y | 1 |
| Choi, JW; Im, HT; Kim, YH; Lee, KT; Park, HJ; Won, JH; Yun, KJ | 1 |
| Bonesi, M; Conforti, F; Deguin, B; Loizzo, MR; Menichini, F; Tillequin, F; Tundis, R | 1 |
| Chung, WY; Hwang, YS; Kim, EC; Kim, J; Park, HJ; Park, KK | 1 |
| Chen, L; Li, Y; Tan, L; Xu, H | 1 |
| Asnaashari, S; Fathiazad, F; Hamedeyazdan, S; Naseri, N; Sharifi, S | 1 |
7 other study(ies) available for buddlejasaponin iv and beta-escin
| Article | Year |
|---|---|
Four new triterpenoid saponins from the roots of Bupleurum rigidum.
Topics: Apiaceae; Carbohydrate Sequence; China; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Plant Roots; Plants, Medicinal; Saponins; Spectrometry, Mass, Fast Atom Bombardment; Triterpenes | 2000 |
[Determination of buddlejasaponin IV in Clinòpodium Linn. by HPLC].
Topics: Chromatography, High Pressure Liquid; Lamiaceae; Plants, Medicinal; Saponins; Triterpenes | 1999 |
Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation.
Topics: Animals; Blotting, Western; Cell Line; Cyclooxygenase 2; Dose-Response Relationship, Drug; Edema; Electrophoretic Mobility Shift Assay; Gene Expression; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Protein Binding; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2006 |
Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae).
Topics: Animals; Antineoplastic Agents, Phytogenic; Apiaceae; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Macrophages; Mice; Neoplasms; Nitric Oxide; Oleanolic Acid; Plant Roots; Saponins; Triterpenes | 2009 |
Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes.
Topics: Alphapapillomavirus; Antineoplastic Agents, Phytogenic; Apiaceae; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Humans; Keratinocytes; Mitochondria; Mouth Mucosa; Mouth Neoplasms; Nuclear Proteins; Phosphorylation; Phytotherapy; Plant Extracts; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Salivary Proline-Rich Proteins; Saponins; Triterpenes; Tumor Necrosis Factors; Tumor Protein p73; Tumor Suppressor Proteins | 2011 |
A simple and sensitive UHPLC-MS/MS method for quantification of buddlejasaponin IV in rat plasma and its application to a pharmacokinetic study.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Saponins; Tandem Mass Spectrometry; Triterpenes | 2016 |
Anticancer effect of buddlejasaponin IV and buddlejasaponin IVa from Clinopodium umbrosum on oral cancer cells (HN-5).
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Endothelial Cells; Humans; Lamiaceae; Mouth Neoplasms; Plant Extracts; Saponins | 2022 |